Earnings History Data for EyePoint Pharmaceuticals, Inc. (EYPT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

EyePoint Pharmaceuticals, Inc.

EyePoint Pharmaceuticals Inc. operates as a biopharmaceutical company. It engaged in the development of drug devices to treat debilitating diseases of the eye disorders and other chronic conditions. The company's product candidate consists of DEXYCU(TM). EyePoint Pharmaceuticals Inc., formerly known as pSivida Corp., is headquartered in Watertown, MA.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-11-2024	PM		EYPT	EyePoint Pharmaceuticals, Inc.	626.16	-0.54	-0.48	-0.33	EyePoint Pharmaceuticals GAAP EPS of -$0.54, revenue of $10.5M [11/7/2024 9:11 AM]	11.57	-0.51 (-4.18%)	12.50	0.42 (3.48%)	5.86 - 30.99	537,634	1,570,000	1,252
EyePoint Pharmaceuticals GAAP EPS of -$0.54, revenue of $10.5M [11/7/2024 9:11 AM] EyePoint Pharmaceuticals: Q3 Earnings Snapshot [2024-11-07 07:37AM] EyePoint Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Corporate Developments [2024-11-07 07:00AM]
07-03-2024	PM		EYPT	EyePoint Pharmaceuticals, Inc.	902.86	-0.33	-0.60	-0.61	EyePoint Pharmaceuticals GAAP EPS of -$0.33 beats by $0.16, revenue of $14M beats by $5.3M [3/7/2024 7:04 AM]	25.24	-0.50 (-1.94%)	26.26	0.52 (2.02%)	2.21 - 30.99	681,481	1,200,000	4,242
EyePoint Pharmaceuticals Q4 2023 Earnings Preview [3/6/2024 10:28 AM] EyePoint Pharmaceuticals GAAP EPS of -$0.33 beats by $0.16, revenue of $14M beats by $5.3M [3/7/2024 7:04 AM]
01-11-2023	PM		EYPT	EyePoint Pharmaceuticals, Inc.	199.76	-0.33	-0.62	-0.49	EyePoint Pharmaceuticals beats Q3 top and bottom line estimates [11/1/2023 7:20 AM]	7.21	1.20 (19.85%)	0.0	0.0 (0.00%)	2.19 - 15.63	854,698	510,000	0
EyePoint Pharmaceuticals Q3 2023 Earnings Preview [10/31/2023 12:01 PM] EyePoint Pharmaceuticals beats Q3 top and bottom line estimates [11/1/2023 7:20 AM]
02-08-2023	PM		EYPT	EyePoint Pharmaceuticals, Inc.	428.77	-0.61	0.41	-0.52	EyePoint Pharmaceuticals misses top and bottom line estimates [8/2/2023 7:11 AM]	12.80	0.10 (0.79%)	11.85	-0.85 (-6.69%)	2.19 - 12.98	741,576	600,000	63,224
EyePoint Pharmaceuticals Q2 2023 Earnings Preview [8/1/2023 1:49 PM] EyePoint Pharmaceuticals misses top and bottom line estimates [8/2/2023 7:11 AM]
03-05-2023	PM	7:00 AM ET (May 3)	EYPT	EyePoint Pharmaceuticals, Inc.	227.76	-0.56	-0.65	-0.52	EyePoint Pharmaceuticals GAAP EPS of -$0.56 beats by $0.13, revenue of $7.68M beats by $0.11M [5/3/2023 7:10 AM]	7.96	1.46 (22.57%)	6.99	0.50 (7.70%)	2.19 - 12.32	1,060,661	3,590,000	5,650
EyePoint Pharmaceuticals Q1 2023 Earnings Preview [5/2/2023 12:47 PM] EyePoint Pharmaceuticals GAAP EPS of -$0.56 beats by $0.13, revenue of $7.68M beats by $0.11M [5/3/2023 7:10 AM] EyePoint stock soars 20% after Q1 sees growth in Yutiq sales [5/3/2023 1:01 PM]
02-03-2023	PM	7:00 AM ET (Mar 2)	EYPT	EyePoint Pharmaceuticals, Inc.	126.45	-0.61	-0.62	-0.59	EyePoint Pharmaceuticals GAAP EPS of -$1.16 misses by $0.54, revenue of $10.53M beats by $0.13M [3/2/2023 7:03 AM]	2.87	-0.30 (-9.46%)	0.0	0.0 (0.00%)	2.19 - 14.41	327,804	200,000	0
EyePoint Pharmaceuticals Q4 2022 Earnings Preview [3/1/2023 12:55 PM] EyePoint Pharmaceuticals GAAP EPS of -$1.16 misses by $0.54, revenue of $10.53M beats by $0.13M [3/2/2023 7:03 AM] EyePoint stock dips as Q4 net loss widens, revenue falls [3/2/2023 12:01 PM]
02-11-2022	PM	7:00 AM ET (Nov 2)	EYPT	EyePoint Pharmaceuticals, Inc.	183.99	-0.49	-0.70	-0.58	EyePoint Pharmaceuticals GAAP EPS of -$0.49 beats by $0.16, revenue of $10.01M misses by $0.91M [11/2/2022 7:12 AM]	5.15	-0.27 (-4.98%)	5.42	0.0 (0.00%)	4.89 - 21.50	145,306	90,000	684
EyePoint Pharmaceuticals GAAP EPS of -$0.49 beats by $0.16, revenue of $10.01M misses by $0.91M [11/2/2022 7:12 AM] EyePoint Pharmaceuticals Reports Third Quarter 2022 Financial Results and Highlights Recent Corporate Developments [Nov-02-22 07:00AM]
03-08-2022	PM	7:30 AM ET (Aug 3)	EYPT	EyePoint Pharmaceuticals, Inc.	364.30	-0.52	-0.57	-0.35	EyePoint Pharmaceuticals GAAP EPS of -$0.52 misses by $0.01, revenue of $11.6M beats by $0.74M [8/3/2022 7:01 AM]	10.15	0.87 (9.38%)	9.28	0.0 (0.00%)	7.00 - 21.50	156,940	210,000	82,277
EyePoint Pharmaceuticals GAAP EPS of -$0.52 misses by $0.01, revenue of $11.6M beats by $0.74M [8/3/2022 7:01 AM] EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences [Aug-02-22 07:00AM] EyePoint Pharmaceuticals Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate Developments [Aug-03-22 07:00AM]
04-05-2022	PM	7:00 AM ET (May 4)	EYPT	EyePoint Pharmaceuticals	385.00	-0.52	-0.50	0.00	EyePoint Pharmaceuticals GAAP EPS of -$0.56 in-line, revenue of $9.3M misses by $0.59M [5/4/2022 7:34 AM]	12.13	0.25 (2.10%)	11.88	0.0 (0.00%)	7.30 - 21.50	96,085	100,000	4,356
EyePoint Pharmaceuticals Q1 2022 Earnings Preview [5/3/2022 11:18 AM] EyePoint Pharmaceuticals GAAP EPS of -$0.56 in-line, revenue of $9.3M misses by $0.59M [5/4/2022 7:34 AM] EyePoint Q1 net loss widens Y/Y; inks license deal with China's Betta for EYP-1901 [5/4/2022 8:30 AM] EyePoint Pharmaceuticals Announces Expanded License Agreement with Betta Pharmaceuticals for EYP-1901 in China, Hong Kong, Macau and Taiwan [May-04-22 07:00AM] EyePoint Pharmaceuticals Reports First Quarter 2022 Financial Results and Highlights Recent Corporate Developments [May-04-22 07:30AM] EyePoint Pharmaceuticals (EYPT) Reports Q1 Loss, Lags Revenue Estimates [May-04-22 08:45AM]
03-03-2022	PM	7:00 AM ET (Mar 3)	EYPT	EyePoint Pharmaceuticals, Inc.	337.30	-0.59	-0.50	-1.01	EyePoint Pharmaceuticals GAAP EPS of -$0.59 misses by $0.03, revenue of $11.54M beats by $1.75M [3/3/2022 7:02 AM]	11.04	1.23 (12.49%)	9.81	0.0 (0.00%)	7.30 - 21.50	124,658	190,000	2,317
EyePoint Pharmaceuticals GAAP EPS of -$0.59 misses by $0.03, revenue of $11.54M beats by $1.75M [3/3/2022 7:02 AM] EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Highlights Recent Corporate Developments [Mar-03-22 07:00AM] EyePoint Pharmaceuticals (EYPT) Reports Q4 Loss, Tops Revenue Estimates [Mar-03-22 08:15AM]
03-11-2021	PM	7:00 AM ET (Nov 3)	EYPT	EyePoint Pharmaceuticals, Inc.	349.27	-0.58	-0.47	-0.30	EyePoint Pharmaceuticals EPS misses by $0.18, misses on revenue [11/3/2021 7:10 AM]	12.56	0.31 (2.50%)	12.10	-0.15 (-1.22%)	3.70 - 15.06	380,528	140,000	200
EyePoint Pharmaceuticals Q3 2021 Earnings Preview [11/2/2021 10:25 AM] EyePoint Pharmaceuticals EPS misses by $0.18, misses on revenue [11/3/2021 7:10 AM] EyePoint Pharmaceuticals Reports Third Quarter 2021 Financial Results and Highlights Recent Corporate Developments [Nov-03-21 07:00AM] EyePoint Pharmaceuticals (EYPT) Reports Q3 Loss, Lags Revenue Estimates [Nov-03-21 08:25AM]
04-08-2021	PM	7:00 AM ET (Aug 4)	EYPT	EyePoint Pharmaceuticals, Inc.	236.25	-0.35	-0.44	1.00	EyePoint Pharmaceuticals EPS beats by $0.09, beats on revenue [8/4/2021 7:12 AM]	8.71	0.15 (1.75%)	8.71	0.0 (0.00%)	3.51 - 15.06	152,828	110,000	1,028
EyePoint Pharmaceuticals EPS beats by $0.09, beats on revenue [8/4/2021 7:12 AM] EyePoint Pharmaceuticals (NASDAQ:EYPT) Has Debt But No Earnings; Should You Worry? [Aug-03-21 03:31AM] EyePoint Pharmaceuticals Reports Second Quarter 2021 Financial Results and Highlights Recent Corporate Developments [Aug-04-21 07:00AM] EyePoint Pharmaceuticals (EYPT) Reports Q2 Loss, Tops Revenue Estimates [Aug-04-21 08:25AM]
05-05-2021	PM	7:00 AM ET (May 5)	EYPT	EyePoint Pharmaceuticals, Inc.	307.25	-0.50	-0.52	-1.10	EyePoint Pharmaceuticals EPS beats by $0.01, misses on revenue [5/5/2021 7:09 AM]	10.85	0.44 (4.23%)	0.0	0.0 (0.00%)	3.51 - 15.06	156,074	150,000	0
EyePoint Pharmaceuticals EPS beats by $0.01, misses on revenue [5/5/2021 7:09 AM] EyePoint Pharmaceuticals, Inc. to Host Earnings Call [May-05-21 06:45AM] EyePoint Pharmaceuticals Reports First Quarter 2021 Financial Results and Highlights Recent Corporate Developments [May-05-21 07:00AM] EyePoint Pharmaceuticals (EYPT) Reports Q1 Loss, Misses Revenue Estimates [May-05-21 08:45AM]
04-03-2021	PM	7:00 AM ET (Mar 4)	EYPT	EyePoint Pharmaceuticals, Inc.	310.07	-1.01	0.45	-0.90	EyePoint Pharmaceuticals EPS misses by $0.90, misses on revenue [3/4/2021 7:02 AM]	9.62	-1.98 (-17.07%)	10.81	-0.79 (-6.81%)	3.51 - 15.06	753,624	300,819	14,126
EyePoint Pharmaceuticals EPS misses by $0.90, misses on revenue [3/4/2021 7:02 AM] EyePoint Pharmaceuticals, Inc. to Host Earnings Call [Mar-04-21 06:30AM]
05-11-2020	PM	7:00 AM ET (Nov 5)	EYPT	EyePoint Pharmaceuticals, Inc.	50.62	-0.30	-0.05	-0.14	EyePoint Pharmaceuticals EPS beats by $0.01, beats on revenue [11/5/2020 7:11 AM]	0.3916	-0.01 (-2.42%)	0.3916	0.0 (0.00%)	0.35 - 2.41	901,392	849,002	194

05-08-2020	PM	7:00 AM ET (Aug 5)	EYPT	EyePoint Pharmaceuticals, Inc.	88.57	-1.00	-0.11	-0.11	EyePoint Pharmaceuticals EPS beats by $0.01, beats on revenue [8/5/2020 7:05 AM]	0.6874	-0.04 (-5.82%)	0.71	-0.02 (-2.73%)	0.66 - 2.69	570,420	387,389	35,724

06-05-2020	PM		EYPT	EyePoint Pharmaceuticals, Inc.	115.15	-1.10	-0.09	-0.16	EyePoint Pharmaceuticals EPS misses by $0.01, beats on revenue [5/6/2020 7:04 AM]	0.8952	-0.03 (-3.02%)	0.90	0.0 (0.54%)	0.70 - 2.69	395,267	339,858	10,311